Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Early and long-standing rheumatoid arthritis: Distinct molecular signatures identified by gene-expression profiling in synovia
Arthritis Research & Therapy, 07/01/09
Lequerre T et al. – Study reports that the early and long standing (LS) rheumatoid arthritis (RA) have distinct molecular signatures with different biological processes participating at different times during the course of the disease, suggesting that better knowledge of the main biological processes involved at a given RA stage might help to choose the most appropriate treatment.
Methods- Study compares the molecular profiles of early and LS RA versus control synovia
- Synovial biopsies obtained by arthroscopy from 15 pts:
- 4 early untreated RA
- 4 treated LS RA and
- 7 controls
- who had traumatic or mechanical lesions
- Extracted mRNAs were used for large-scale gene-expression profiling
- Differential gene-expression were linked to biological processes involved in each situation
- 3 combinations of 719, 116, and 52 transcripts discriminated, respectively, early from LS RA, and early or LS RA from normal synovial
- Several gene clusters and distinct molecular signatures specifically expressed during early or LS RA
- This suggests the involvement of different pathophysiological mechanisms during the course of RA
Related Articles
Treatment of early RA with infliximab is beneficial
American Pharmacists Association, 11/06/09
Relevance Score: 82%%
Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: results from the NOR-VEAC cohort
Arthritis Research & Therapy, 10/02/09
Relevance Score: 82%%
Pain in arthritis
European Journal of Pain, 11/17/09
Relevance Score: 81%%
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents. A Cost-Effectiveness Analysis
Annals of Internal Medicine, 11/05/09
Relevance Score: 81%%
Articular ultrasonography in rheumatoid arthritis
International Journal of Clinical Rheumatology, 10/16/09
Relevance Score: 81%%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Urinary cadmium, osteopenia, and osteoporosis in the US population
Osteoporosis International, 11/27/09
Plasma level of myeloperoxidase in children with juvenile idiopathic arthritis (a pilot study)
Central European Journal of Medicine, 11/25/09
Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid
Osteoporosis International, 11/25/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety of TNF blocking agents in rheumatic patients with serology suggesting past-hepatitis B state: Results from a cohort of 21 patients
Arthritis Research & Therapy, 11/27/09
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production
Arthritis Research & Therapy, 11/25/09
Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis
Annals of Rheumatic Diseases, 11/24/09
Sponsor
Article Search
Sponsor


See Latest Articles


